|| Checking for direct PDF access through Ovid
Since 1994 Sacral neuromodulation (SNM) has gradually been applied more and more in the treatment of faecal incontinence, however no long-term data in a substantial group of patients have been published up to date.Starting in 2000, data from our first 50 patients with faecal incontinence who qualified for permanent SNM were included in this study. With a 3-week bowel habits diary efficacy was assessed and the Quality of life scores were obtained by the Faecal incontinence quality of life questionnaire (FIQOL) and the standard short form health survey questionnaire (SF-36).During a median follow-up of 7.1 years the continence improvement of 50% or more maintained in forty-two (84%) patients. Median incontinent episodes and days per week decreased significantly during trial screening and follow-up (P < 0.002). The FIQOL scale showed a significant improvement in all four categories, and in some subscales of the SF-36 QOL questionnaire.Initial improvement in continence with SNM could not be maintained in all patients, however with an overall success rate of 80% after permanent implant SNM is a safe and effective longterm treatment in patients with faecal incontinence.